This inventor holds 3 USPTO granted patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 1996-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1998
Title: The Innovations of Peter Sayre
Introduction
Peter Sayre is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of immunology. With a total of 3 patents to his name, Sayre's work has had a profound impact on the understanding and treatment of T-lymphocyte activation.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Recombinant DNA-produced T11 and fragments thereof." This patent describes a cDNA sequence encoding human T11 or a fragment thereof, which is capable of inhibiting T-lymphocyte activation. This innovation holds promise for advancing therapeutic strategies in immunology.
Career Highlights
Peter Sayre is currently affiliated with the Dana-Farber Cancer Institute Inc., where he continues to push the boundaries of cancer research and treatment. His work at this prestigious institution has allowed him to collaborate with leading experts in the field, further enhancing the impact of his inventions.
Collaborations
Some of his notable coworkers include Ellis L. Reinherz and Neil Richardson. Their collaborative efforts have contributed to the advancement of research in immunology and cancer treatment.
Conclusion
Peter Sayre's contributions to biotechnology and immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in the field, paving the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile